Increased IFN-λ2/IL-28A epithelial expression in MSGs and IFN-λ1/IL-29 levels in the periphery were detected in patients with pSS in comparison to sicca controls [72]. This evidence concerns the gene IFNL1 and peeling skin syndrome.